We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ALEMG market cap is 12.28M. The company's latest EPS is EUR 4.5602 and P/E is 1.47.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 77.43M | 193.68M | 112.31M | 58.95M | 37.43M |
| Operating Income | -1.61M | 33.13M | 8.44M | -2.05M | -1.26M |
| Net Income | -3.65M | 22.66M | 2.26M | -5.93M | 13.11M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 53.98M | 92.62M | 72.72M | 59.87M | 46.26M |
| Total Liabilities | 37.94M | 53.69M | 31.48M | 24.99M | 23.67M |
| Total Equity | 16.04M | 38.93M | 41.24M | 34.88M | 22.59M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -983k | 13.5M | 19.25M | -1.05M | N/A |
| Investing | -1.23M | -592k | -1.13M | -1.07M | N/A |
| Financing | 3.47M | 9.29M | -1.25M | -2.41M | N/A |
| Market Cap | 12.28M |
| Price to Earnings Ratio | 1.47 |
| Price to Sales Ratio | 0.51 |
| Price to Cash Ratio | 1.02 |
| Price to Book Ratio | 0.85 |
| Dividend Yield | - |
| Shares Outstanding | 2.87M |
| Average Volume (1 week) | 345 |
| Average Volume (1 Month) | 519 |
| 52 Week Change | -11.04% |
| 52 Week High | 6.60 |
| 52 Week Low | 4.10 |
| Spread (Intraday) | 0.13 (3.02%) |
| Company Name | Labo Euromedis |
| Address |
z.a. la tuilerie neuilly-sur-marne, seine-saint-denis 60290 |
| Website | https://www.euromedis.fr |
| Industry | ortho,prosth,surg appl,suply (3842) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
